267 related articles for article (PubMed ID: 21510763)
1. Analysis of polar metabolites by hydrophilic interaction chromatography--MS/MS.
Jian W; Xu Y; Edom RW; Weng N
Bioanalysis; 2011 Apr; 3(8):899-912. PubMed ID: 21510763
[TBL] [Abstract][Full Text] [Related]
2. Bioanalytical hydrophilic interaction chromatography: recent challenges, solutions and applications.
Xu RN; Rieser MJ; El-Shourbagy TA
Bioanalysis; 2009 Apr; 1(1):239-53. PubMed ID: 21083199
[TBL] [Abstract][Full Text] [Related]
3. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for drug development.
Hsieh Y
Curr Drug Discov Technol; 2010 Sep; 7(3):223-31. PubMed ID: 20843291
[TBL] [Abstract][Full Text] [Related]
4. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
Hsieh Y
J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
[TBL] [Abstract][Full Text] [Related]
5. HILIC-MS/MS method development for targeted quantitation of metabolites: practical considerations from a clinical diagnostic perspective.
Rappold BA; Grant RP
J Sep Sci; 2011 Dec; 34(24):3527-37. PubMed ID: 22084005
[TBL] [Abstract][Full Text] [Related]
6. Hydrophilic interaction liquid chromatography in the separation of a moderately lipophilic drug from its highly polar metabolites--the cardioprotectant dexrazoxane as a model case.
Kovaříková P; Stariat J; Klimeš J; Hrušková K; Vávrová K
J Chromatogr A; 2011 Jan; 1218(3):416-26. PubMed ID: 21168142
[TBL] [Abstract][Full Text] [Related]
7. Quantification of polar drugs in human plasma with liquid chromatography-tandem mass spectrometry.
Deng P; Chen X; Zhong D
Bioanalysis; 2009 Apr; 1(1):187-203. PubMed ID: 21083196
[TBL] [Abstract][Full Text] [Related]
8. Application of hydrophilic interaction chromatography for the analysis of polar contaminants in food and environmental samples.
van Nuijs AL; Tarcomnicu I; Covaci A
J Chromatogr A; 2011 Sep; 1218(35):5964-74. PubMed ID: 21316059
[TBL] [Abstract][Full Text] [Related]
9. Hydrophilic interaction chromatography (HILIC) for LC-MS/MS analysis of monoamine neurotransmitters.
Danaceau JP; Chambers EE; Fountain KJ
Bioanalysis; 2012 Apr; 4(7):783-94. PubMed ID: 22512797
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in application of hydrophilic interaction chromatography for quantitative bioanalysis.
Jian W; Edom RW; Xu Y; Weng N
J Sep Sci; 2010 Mar; 33(6-7):681-97. PubMed ID: 20155745
[TBL] [Abstract][Full Text] [Related]
11. Applications of HILIC for targeted and non-targeted LC/MS analyses in drug discovery.
Onorato JM; Langish R; Bellamine A; Shipkova P
J Sep Sci; 2010 Mar; 33(6-7):923-9. PubMed ID: 20127913
[TBL] [Abstract][Full Text] [Related]
12. Hydrophilic Interaction Liquid Chromatography/Mass Spectrometry: An Attractive and Prospective Method for the Quantitative Bioanalysis in Drug Metabolism.
Li Z; Han J; Sun SA; Chen K; Tang DQ
Curr Drug Metab; 2016; 17(4):386-400. PubMed ID: 26651973
[TBL] [Abstract][Full Text] [Related]
13. Systematic comparison of sensitivity between hydrophilic interaction liquid chromatography and reversed phase liquid chromatography coupled with mass spectrometry.
Periat A; Boccard J; Veuthey JL; Rudaz S; Guillarme D
J Chromatogr A; 2013 Oct; 1312():49-57. PubMed ID: 24034137
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
[TBL] [Abstract][Full Text] [Related]
15. Ultra-performance hydrophilic interaction liquid chromatography/tandem mass spectrometry for the determination of everolimus in mouse plasma.
Hsieh Y; Galviz G; Long BJ
Rapid Commun Mass Spectrom; 2009 May; 23(10):1461-6. PubMed ID: 19350527
[TBL] [Abstract][Full Text] [Related]
16. Retention pattern profiling of fungal metabolites on mixed-mode reversed-phase/weak anion exchange stationary phases in comparison to reversed-phase and weak anion exchange separation materials by liquid chromatography-electrospray ionisation-tandem mass spectrometry.
Apfelthaler E; Bicker W; Lämmerhofer M; Sulyok M; Krska R; Lindner W; Schuhmacher R
J Chromatogr A; 2008 May; 1191(1-2):171-81. PubMed ID: 18199445
[TBL] [Abstract][Full Text] [Related]
17. On-line desorption of dried blood spots coupled to hydrophilic interaction/reversed-phase LC/MS/MS system for the simultaneous analysis of drugs and their polar metabolites.
Thomas A; Déglon J; Steimer T; Mangin P; Daali Y; Staub C
J Sep Sci; 2010 Mar; 33(6-7):873-9. PubMed ID: 20029845
[TBL] [Abstract][Full Text] [Related]
18. Systematic evaluation of matrix effects in hydrophilic interaction chromatography versus reversed phase liquid chromatography coupled to mass spectrometry.
Periat A; Kohler I; Thomas A; Nicoli R; Boccard J; Veuthey JL; Schappler J; Guillarme D
J Chromatogr A; 2016 Mar; 1439():42-53. PubMed ID: 26387791
[TBL] [Abstract][Full Text] [Related]
19. Quantitative metabolite profiling utilizing parallel column analysis for simultaneous reversed-phase and hydrophilic interaction liquid chromatography separations combined with tandem mass spectrometry.
Klavins K; Drexler H; Hann S; Koellensperger G
Anal Chem; 2014 May; 86(9):4145-50. PubMed ID: 24678888
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
